Inventor · disambiguated record
Ravindra Kumar
Also filed as: KUMAR RAVINDRA
157 granted patents·105 pending applications·1,974 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
262 records- 0199US10973880B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Apr 13, 2021·7 cites·29 claims
- 0299US8703694B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2012·Granted Apr 22, 2014·43 cites·42 claims
- 0399US8703927B2Isolated nucleotide sequences encoding GDF trapsSEEHRA JASBIR·Filed 2012·Granted Apr 22, 2014·57 cites·9 claims
- 0499US8343933B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2010·Granted Jan 1, 2013·91 cites·25 claims
- 0599US8216997B2Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activatorsSEEHRA JASBIR·Filed 2010·Granted Jul 10, 2012·100 cites·20 claims
- 0699US8178488B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2010·Granted May 15, 2012·92 cites·18 claims
- 0799US8058229B2Method of increasing red blood cell levels or treating anemia in a patientSEEHRA JASBIR·Filed 2009·Granted Nov 15, 2011·97 cites·28 claims
- 0899US7842663B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2008·Granted Nov 30, 2010·135 cites·15 claims
- 0998US11219666B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Jan 11, 2022·5 cites·29 claims
- 1098US11065303B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Jul 20, 2021·6 cites·26 claims
- 1198US10946067B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Mar 16, 2021·6 cites·30 claims
- 1298US10889626B2Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2020·Granted Jan 12, 2021·4 cites·25 claims
- 1398US10829532B2Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2020·Granted Nov 10, 2020·4 cites·24 claims
- 1498US10722558B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2017·Granted Jul 28, 2020·15 cites·42 claims
- 1598US10695405B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2018·Granted Jun 30, 2020·13 cites·17 claims
- 1698US8361957B2Isolated GDF trap polypeptideACCELERON PHARMA INC·Filed 2011·Granted Jan 29, 2013·42 cites·14 claims
- 1798US8293881B2Isolated nucleic acid encoding a truncated ActRIIB fusion proteinSEEHRA JASBIR·Filed 2010·Granted Oct 23, 2012·73 cites·9 claims
- 1897US10377996B2Methods of identifying ActRIIB variantsACCELERON PHARMA INC·Filed 2016·Granted Aug 13, 2019·24 cites·11 claims
- 1997US10259861B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2016·Granted Apr 16, 2019·22 cites·11 claims
- 2097US10131700B2Methods for treating refractory anemia with ringed sideroblastsACCELERON PHARMA INC·Filed 2017·Granted Nov 20, 2018·20 cites·25 claims
- 2197US9932379B2Isolated nucleotide sequences encoding GDF trapsACCELERON PHARMA INC·Filed 2016·Granted Apr 3, 2018·19 cites·12 claims
- 2297US9745559B2Method for decreasing the body fat content in a subject by administering an ActRIIB proteinACCELERON PHARMA INC·Filed 2015·Granted Aug 29, 2017·22 cites·20 claims
- 2397US8173601B2Activin-ActRIIa antagonists and uses for treating multiple myelomaKNOPF JOHN·Filed 2008·Granted May 8, 2012·42 cites·21 claims
- 2496US11622992B2Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2020·Granted Apr 11, 2023·3 cites·20 claims
- 2596US10689427B2Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2018·Granted Jun 23, 2020·7 cites·17 claims
- 2696US10358633B2Method for producing an ActRIIB-Fc fusion polypeptideACCELERON PHARMA INC·Filed 2017·Granted Jul 23, 2019·15 cites·7 claims
- 2796US9809637B2Transforming growth factor beta receptor II fusion polypeptidesACCELERON PHARMA INC·Filed 2016·Granted Nov 7, 2017·19 cites·9 claims
- 2896US9526759B2Activin-actriia antagonists and uses for treating or preventing breast cancerKNOPF JOHN·Filed 2008·Granted Dec 27, 2016·38 cites·34 claims
- 2996US9505813B2Use of GDF traps to treat anemiaACCELERON PHARMA INC·Filed 2013·Granted Nov 29, 2016·20 cites·63 claims
- 3096US9439945B2Isolated nucleotide sequences encoding GDF trapsACCELERON PHARMA INC·Filed 2014·Granted Sep 13, 2016·18 cites·15 claims
- 3196US9399669B2Variants derived from ActRIIBACCELERON PHARMA INC·Filed 2012·Granted Jul 26, 2016·27 cites·29 claims
- 3296US9181533B2Truncated ACTRIIB-FC fusion proteinACCELERON PHARMA INC·Filed 2012·Granted Nov 10, 2015·26 cites·19 claims
- 3396US8138142B2Methods for increasing adiponectin in a patient in need thereofSEEHRA JASBIR·Filed 2010·Granted Mar 20, 2012·82 cites·17 claims
- 3495US11175836B2Enhanced data clock operations in memoryQUALCOMM INC·Filed 2020·Granted Nov 16, 2021·5 cites·42 claims
- 3595US8765663B2Methods for increasing adiponectinSEEHRA JASBIR·Filed 2012·Granted Jul 1, 2014·38 cites·12 claims
- 3695US5827817AP-selectin ligand proteinGENETICS INST·Filed 1995·Granted Oct 27, 1998·146 cites·16 claims
- 3793US11028145B2ALK7:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jun 8, 2021·4 cites·23 claims
- 3893US10358476B2Single arm type I and type II receptor fusion proteins and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Jul 23, 2019·12 cites·16 claims
- 3993US10227393B2TGF-beta superfamily type I and type II receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Mar 12, 2019·9 cites·27 claims
- 4093US9572865B2Activin-actriia antagonists and uses for treating multiple myelomaKNOPF JOHN·Filed 2012·Granted Feb 21, 2017·16 cites·17 claims
- 4192US5840679AMethod of inhibiting P-selectin ligand activityGENETICS INST·Filed 1995·Granted Nov 24, 1998·98 cites·26 claims
- 4292US5728568AHuman GDP-mannose 4,6 dehydrataseGENETICS INST·Filed 1996·Granted Mar 17, 1998·84 cites·7 claims
- 4391US11279746B2ALK4:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2020·Granted Mar 22, 2022·2 cites·11 claims
- 4491US10968282B2Methods for screening compounds for increasing thermogenic adipocytesACCELERON PHARMA INC·Filed 2019·Granted Apr 6, 2021·2 cites·15 claims
- 4591US10738098B2ALK4:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2018·Granted Aug 11, 2020·6 cites·33 claims
- 4691US8051113B1Method and system for managing clustered and non-clustered storage systemsNETAPP INC·Filed 2009·Granted Nov 1, 2011·27 cites·18 claims
- 4790US10501547B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·7 claims
- 4890US9884900B2Methods for treating Janus kinase-associated disorders by administering soluble transforming growth factor beta type II receptorACCELERON PHARMA INC·Filed 2016·Granted Feb 6, 2018·12 cites·34 claims
- 4990US9790284B2Methods for increasing thermogenic adipocytesACCELERON PHARMA INC·Filed 2014·Granted Oct 17, 2017·5 cites·18 claims
- 5090US2025066488A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 262 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ravindra Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →